Tracking Tumorigenesis Through Cell‐Free DNA Analysis: From Premalignant Evolution to Multimodal Surveillance and Early Detection
WIREs Mechanisms of Disease · 2026-11 · 18 (6)
DOI: 10.1002/wsbm.70019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Mechanisms of Disease, online erschienen am 11.11.2026. Verfasst von Yuhui Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, China. Hauptthemen laut MEDLINE: Early Detection of Cancer, Cell-Free Nucleic Acids, Carcinogenesis, Neoplasms. Die Arbeit nennt 134 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, Basic Science (Natural Science) Research General Program of Jiangsu Provincial Colleges and Universities.
Abstract (Originalsprache)
Conventional tissue biopsy remains the clinical standard for diagnosing many cancers, but it provides only a spatially restricted and temporally limited view of disease. Cell‐free DNA (cfDNA) is a minimally invasive source of molecular information that may reflect temporal changes in tissue injury, clonal evolution, and epigenetic remodeling. This review distinguishes early tumorigenesis, premalignant states, preinvasive disease, and early‐stage cancer, and examines how mutational profiling, fragmentomics, DNA methylation, and extracellular vesicles can be used to investigate molecular events across this continuum. The conceptual contribution is to frame cfDNA as a longitudinal readout of somatic evolution rather than solely a one‐time cancer detection assay, while distinguishing direct measurements from computational inferences. We also discuss clonal hematopoiesis, signal dilution, the lack of validated reference standards, and the mismatch between dynamic tumor evolution and static biomarker assays. Longitudinal and multimodal analyses are biologically promising; however, current evidence does not yet demonstrate that cfDNA can directly or continuously monitor malignant transformation. In the near term, its value may lie primarily in risk stratification, mechanistic research, and rigorously validated surveillance of selected high‐risk populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
- Department of Clinical Laboratory, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
- Department of Oncology, University of Cambridge, Cambridge, UK.
ORCID-Profile: Renjun Gu, Hengrui Liu
Förderung
- Natural Science Foundation of Jiangsu Province
- Basic Science (Natural Science) Research General Program of Jiangsu Provincial Colleges and Universities
Zitieren
APA
Sun, Y., Zhang, G., Xu, Z., Chen, Q., Gu, R., & Liu, H. (2026). Tracking Tumorigenesis Through Cell‐Free DNA Analysis: From Premalignant Evolution to Multimodal Surveillance and Early Detection. WIREs Mechanisms of Disease, 18(6). https://doi.org/10.1002/wsbm.70019
Vancouver
Sun Y, Zhang G, Xu Z, Chen Q, Gu R, Liu H. Tracking Tumorigenesis Through Cell‐Free DNA Analysis: From Premalignant Evolution to Multimodal Surveillance and Early Detection. WIREs Mechanisms of Disease. 2026;18(6). doi:10.1002/wsbm.70019
BibTeX
@article{Sun2026,
author = {Sun, Yuhui and Zhang, Guihong and Xu, Zheng and Chen, Qi and Gu, Renjun and Liu, Hengrui},
title = {Tracking Tumorigenesis Through Cell‐Free DNA Analysis: From Premalignant Evolution to Multimodal Surveillance and Early Detection},
journal = {WIREs Mechanisms of Disease},
year = {2026},
volume = {18},
number = {6},
doi = {10.1002/wsbm.70019}
}
EUVIMED